Day: December 24, 2020

TORONTO, 24 déc. 2020 (GLOBE NEWSWIRE) — Doré Copper Mining Corp. (la « Société » ou « Doré Copper ») (TSXV: DCMC, OTCQB: DRCMF) est heureuse d’annoncer qu’elle a procédé à la clôture d’une première tranche de son placement privé sans l’entremise d’un courtier annoncé précédemment (le « Placement »), dans le cadre duquel la Société a vendu un total de 5 800 378 actions ordinaires du capital de la Société (les « Actions offertes ») à un prix de 0,68 $CA par Action offerte, pour un produit brut total de 3 944 257,04 $CA. Une deuxième tranche du Placement devrait être clôturée en janvier.Cormark Securities Inc., Paradigm Capital Inc., Haywood Securities Inc. et Red Cloud Securities Inc. ont agi à titre d’intermédiaires (chacun, un « Intermédiaire ») dans le cadre de la première tranche du Placement....

SANTA CLARA, Calif., Dec. 24, 2020 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (Nasdaq: BRQS, the “Company”), a global provider of embedded software and products for the Internet of Things (IoT), today reported that the Company has entered into Agreements dated December 14, 2020 with its senior lender and LMFA Financing LLC (“LMFA”), a Florida limited liability company and wholly owned subsidiary of LM Funding America, Inc. (Nasdaq: LMFA), in which LMFA is committed to purchase up to be approximately $18 million of debt in tranches, which when completed will eliminate substantially all of the debt with the Company’s senior lender. LMFA will convert the purchased debt into common shares of the Company, pursuant to a court order that allows the conversion shares to be issued as unrestricted securities in a transaction that is exempt...

TORONTO, Dec. 24, 2020 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV: FW) (“Flow Capital” or the “Company”) is announcing that Wedge Networks, Inc. (“Wedge”) has completed a buyout of Flow Capital’s royalty investment for $1,250,000.“The team at Wedge has developed a compelling solution to address cyber security threats. With the increased dependence on telecommuting, due to the ongoing pandemic, and a global digital cold war, safeguards against such threats have become even more critical. Flow Capital is glad to have participated in their growth, and we wish them well,” said Alex Baluta, CEO, Flow Capital.“Partnering with Flow has been very important to Wedge. Alex and his team at Flow demonstrated an ability to understand the capabilities of our innovations and to visualize the potential of our solutions. The past twelve months...

Holmdel, New Jersey., Dec. 24, 2020 (GLOBE NEWSWIRE) — Monmouth Real Estate Investment Corporation (NYSE:MNR) today announced the acquisition of a new 657,518 square foot industrial building located at 3150 Highway 42 in Locust Grove, GA. at a purchase price of $96.7 million. The property is net-leased for 20 years to Home Depot U.S.A., Inc. The building is situated on approximately 130 acres and has a land-to-building ratio of nearly nine times, providing ample opportunity for future development to drive accretive growth.Michael P. Landy, President and CEO, commented, “We are very pleased to announce this high-quality acquisition. A common misconception is that all industrial real estate provides a linkage to the digital economy, but in fact, a new type of industrial real estate has been designed specifically to serve the computer-driven...

BOCA RATON, Fla., Dec. 24, 2020 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it has exercised its right to accelerate the expiry date of subordinate voting share purchase warrants (the “Warrants”) issued to participants in the Company’s previously-announced private placement offerings, which closed in March 2019 (the “Offering”). Participants have thirty days from the date of notice of the acceleration to exercise their Warrants.“We are strategically expanding our footprint and scaling our operations in some of the most attractive markets in the Cannabis industry,” said Jim Cacioppo, Chief Executive Officer, Chairman and Founder of Jushi. “The funds raised through the exercise of...

TORONTO, Dec. 24, 2020 (GLOBE NEWSWIRE) — Pinehurst Capital I Inc. (TSXV: PHT.P) (the “Corporation” or “Pinehurst“), a capital pool company listed on the TSX Venture Exchange, announces a change to the location of its annual and special meeting to be held on December 29, 2020 at 1:00 p.m. (Toronto time) (the “Meeting“).The new location for the Meeting will be 130 King St. West, Suite 2210, Toronto, Ontario, M5X 1E4. There is no change in the date or time of the Meeting.Vote by proxy – Instructions for voting by proxy are contained in the November 26, 2020 Notice of Meeting and accompanying Management Information Circular and Instrument of Proxy sent to shareholders.For more information concerning the Corporation, please refer to the Corporation’s profile on the SEDAR website at www.sedar.com.For...

VANCOUVER, British Columbia, Dec. 24, 2020 (GLOBE NEWSWIRE) — Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce that it has closed its oversubscribed, non-brokered private placement. The private placement, consisting of 42,477,770 Units at a price of $0.065 per Unit, raised gross proceeds of $2,761,055 (the “Offering”). Each Unit consists of one common share and one share purchase warrant, with each warrant entitling the holder to purchase an additional common share at a price of $0.10 until December 22, 2022. Red Cloud Securities, Inc. acted as a finder with respect to the Offering.All securities issued in the Offering are subject to a hold period expiring on April 24, 2021. In connection with completion of the Offering, the Company paid $137,455 and issued 2,114,748...

MONTREAL, Dec. 24, 2020 (GLOBE NEWSWIRE) — Harfang Exploration Inc. (“Harfang” or the “Corporation”) (TSX-V: HAR) announces today the closing of a non-brokered private placement.The private placement (the “Offering”) consists in the issuance of 2 727 274 flow-through common shares (the “FT Shares”) at a price of $0.55 per FT Share for an amount of $1 500 000.All securities issued in connection with this Placement are subject to a hold period of four months and one day. The Offering is subject to the approval of the TSX Venture Exchange.The proceeds of the Offering will be used in particular for a significant exploration program on the Serpent property, 100% owned by Harfang.About HarfangHarfang is a mining exploration company whose primary mission is to discover new gold districts in the province of Québec. Harfang’s development...

MONTRÉAL, 24 déc. 2020 (GLOBE NEWSWIRE) — Harfang Exploration Inc. (« Harfang » ou la « société ») (TSX-V : HAR) annonce aujourd’hui la clôture d’un placement privé sans intermédiaire.Le placement privé (le « placement ») consiste en l’émission de 2 727 274 actions ordinaires accréditives à un prix de 0,55 $ par action pour un montant de 1 500 000 $.Tous les titres émis dans le cadre du placement sont assujettis à une période de détention de quatre mois et un jour. Le placement est assujetti à l’approbation de la Bourse de croissance TSX.Le produit de ce placement sera affecté en particulier à des travaux d’exploration de grande envergure sur la propriété Serpent, détenue à 100% par Harfang et au fonds de roulement de la société.À propos d’HarfangHarfang est une société d’exploration minière dont la mission première est la découverte...

VANCOUVER, British Columbia, Dec. 24, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that the last patient from the Phase 2b part of its multinational Phase 2b/3 human study of NP-120 (Ifenprodil) for the treatment of COVID-19, has now completed treatment as well as the required two-week follow up.The Company announced positive trending interim data for the Phase 2b part of it Phase 2b/3 Ifenprodil COVID-19 Study, on December 15, 2020. The Company is projecting the final data set will be available before the end of February, 2020.“This is another important step for the Company,” said Christopher J. Moreau, CEO of Algernon Pharmaceuticals. “Now that we have announced final patient...